Search Results - "Focan, Ch"

HER-2 and topo-isomerase IIα as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide by Di Leo, A., Larsimont, D., Gabcberg, D., Jarvinen, T., Beauduin, M., Vindevoghel, A., Michel, J., Focan, Ch, Ries, F., Gobert, Ph, Closon-Dejardin, M.-T., Dolci, S., Rouas, G., Paesmans, M., Lobelle, J.-P., Isola, J., Piccart, M. J.

“…Background: The predictive role of HER-2 in node-positive breast cancer patients receiving CMF or an anthracycline-based adjuvant therapy remains unclear. In…”
Get full text

The Sentinel Lymph Node Biopsy in Breast Cancer by Weerts, J.M., Maweja, S., Tamigneaux, I., Dallemagne, B., Jourdan, J.L., Markiewicz, S., Monami, B., Wahlen, Ch, Lastra, M., Hénon, V., Gomez, P., Lilet, H., Dwelshauwers, J., Graas, M.P., Focan, Ch, Lipczei, B., Abraham, F., Jehaes, C.

“…Objective: To evaluate the possibility and accuracy of this new diagnostic approach to the breast cancer disease in our centre. Material and methods: Since…”
Get full text